KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $1.1 billion.

  • Bristol Myers Squibb's Profit After Tax rose 140694.44% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.1 billion, marking a year-over-year increase of 17898.21%. This contributed to the annual value of $7.1 billion for FY2025, which is 17884.44% up from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's Profit After Tax is $1.1 billion, which was up 140694.44% from $2.2 billion recorded in Q3 2025.
  • Bristol Myers Squibb's Profit After Tax's 5-year high stood at $2.5 billion during Q1 2025, with a 5-year trough of -$11.9 billion in Q1 2024.
  • In the last 5 years, Bristol Myers Squibb's Profit After Tax had a median value of $1.6 billion in 2022 and averaged $976.0 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first plummeted by 62540.8% in 2024, then skyrocketed by 140694.44% in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Profit After Tax (Quarter) stood at $2.4 billion in 2021, then fell by 14.63% to $2.0 billion in 2022, then decreased by 12.99% to $1.8 billion in 2023, then tumbled by 95.91% to $72.0 million in 2024, then skyrocketed by 1406.94% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q4 2025, $2.2 billion for Q3 2025, and $1.3 billion during Q2 2025.